Ryder SystemNYSE: R

DehydraTECH-liraglutide and a select DehydraTECH-CBD formulation were the top performing groups in the Study outperforming the Rybelsus® control group in both body weight-loss, by 11.53% and 10.65% respectively, and in blood sugar, by 11.13% and 3.35% respectively. DehydraTECH-semaglutide compositions with and without SNAC technology outperformed Rybelsus® control in body weight Weight-control improvement demonstrated in ALL study groups during the final 4-weeks Outcomes are strongly supportive of pending Phase 1b Australian human study KELOWNA, BC / ACCESSWIRE / November 20, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it has received final 12-week body weight and blood sugar results from all 12 study groups of the recently completed diabetes animal study WEIGHT-A24-1 (the "Study").

Brisbane, Queensland, Australia--(Newsfile Corp. - November 19, 2024) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to provide a business update on the commercialisation progress of THERMAL-XR® Powered by GMG Graphene.

TORONTO, ON / ACCESSWIRE / November 15, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that it has successfully closed a non-brokered private placement offering ("Offering") of units ("Units"). On closing, the Corporation issued an aggregate of 2,221,334 Units at a price of $CAN 0.30 per Unit for aggregate gross proceeds of approximately $CAN 666,400.

CLEVELAND, OH / ACCESSWIRE / November 14, 2024 / Mace Security International (OTCQB:MACE) today announced its September 30, 2024 Unaudited Financial Statements and Notes and 2024 Q3 OTCQB Quarterly Report cannot be filed within the prescribed date because the Company requires additional time to prepare its financial statements and quarterly reports. The Company anticipates filing these two reports before the end of the cure period under the OTCQB Standards on December 30, 2024.

TORONTO, ON / ACCESSWIRE / November 12, 2024 / Theralase® Technologies Inc. ("Theralase ®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that the Company proposes to extend the expiry date of 1,000,000 share purchase warrants ("Warrants") from November 17, 2024 to November 17, 2027. The Warrants were issued on November 17, 2022, pursuant to a private placement involving the issuance of 1,000,000 units of the Company.

BOULDER, CO / ACCESSWIRE / November 11, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced it has received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Microcyn technology-based hydrogel, including improved biocompatibility and extended shelf life. Per this new clearance, Sonoma's Microdacyn® Hydrogel can be used under the supervision of a healthcare professional for management of wounds associated with dermal irritation, sores, injuries and ulcers of dermal tissue, for use on first and second degree burns, and diabetic ulcers, and for the management of mechanically or surgically debrided wounds.

TAMPA BAY, FL / ACCESSWIRE / November 6, 2024 / Atlantic Power & Infrastructure Corp. (OTC PINK:AWSL) is pleased to announce that its proprietary product, Flexi®-Pave, has proved once again to be a major success for tree surround installations in the City of Las Vegas, Nevada, leading to the approval of more planned projects for city maintenance and beautification in the coming year. The product's unique composition allows for flexibility, aeration and filtration while mitigating the liability so often associated with broken concrete and asphalt and tree root hazards.

CALGARY, AB / ACCESSWIRE / November 5, 2024 / NXT Energy Solutions Inc. ("NXT" or the "Company") (TSX:SFD)(OTCQB:NSFDF) is pleased to announce the award of a contract to provide an SFD® survey for AL-Haj Enterprises Private Limited ("AEPL"). Data acquisition operations for this contract are expected to commence in the second quarter of 2025, and NXT's interpretations and recommendations are expected to be delivered during the third quarter of 2025.

Vancouver, British Columbia--(Newsfile Corp. - November 1, 2024) - Jackpot Digital Inc. (TSXV: JJ) (TSXV: JJ.WT.C) (OTCQB: JPOTF) (FSE: LVH3) (the "Company" or "Jackpot"), a leading manufacturer of electronic multiplayer dealerless poker tables, is pleased to announce it has placed an order with its manufacturing partner for 100 additional Jackpot Blitz® dealerless electronic poker tables (ETGs). Production of the units will begin immediately.